Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

476 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictors of Patient and Physician Assessments of Gout Control.
Dalbeth N, Frampton C, Fung M, Baumgartner S, Choi HK. Dalbeth N, et al. Among authors: baumgartner s. Arthritis Care Res (Hoboken). 2023 Jun;75(6):1287-1291. doi: 10.1002/acr.25046. Epub 2022 Dec 28. Arthritis Care Res (Hoboken). 2023. PMID: 36263859
Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study).
Saag KG, Fitz-Patrick D, Kopicko J, Fung M, Bhakta N, Adler S, Storgard C, Baumgartner S, Becker MA. Saag KG, et al. Among authors: baumgartner s. Arthritis Rheumatol. 2017 Jan;69(1):203-212. doi: 10.1002/art.39840. Arthritis Rheumatol. 2017. PMID: 27564409 Clinical Trial.
Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial.
Dalbeth N, Jones G, Terkeltaub R, Khanna D, Kopicko J, Bhakta N, Adler S, Fung M, Storgard C, Baumgartner S, Perez-Ruiz F. Dalbeth N, et al. Among authors: baumgartner s. Arthritis Rheumatol. 2017 Sep;69(9):1903-1913. doi: 10.1002/art.40159. Epub 2017 Aug 4. Arthritis Rheumatol. 2017. PMID: 28597604 Free PMC article. Clinical Trial.
An open-label, 6-month study of allopurinol safety in gout: The LASSO study.
Becker MA, Fitz-Patrick D, Choi HK, Dalbeth N, Storgard C, Cravets M, Baumgartner S. Becker MA, et al. Among authors: baumgartner s. Semin Arthritis Rheum. 2015 Oct;45(2):174-83. doi: 10.1016/j.semarthrit.2015.05.005. Epub 2015 May 21. Semin Arthritis Rheum. 2015. PMID: 26190562 Free article. Clinical Trial.
Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study).
Bardin T, Keenan RT, Khanna PP, Kopicko J, Fung M, Bhakta N, Adler S, Storgard C, Baumgartner S, So A. Bardin T, et al. Among authors: baumgartner s. Ann Rheum Dis. 2017 May;76(5):811-820. doi: 10.1136/annrheumdis-2016-209213. Epub 2016 Nov 7. Ann Rheum Dis. 2017. PMID: 27821644 Free PMC article. Clinical Trial.
476 results